Publications by authors named "Paul Oloo"

Claim this Profile
P
Prospective cohort study to evaluate Lassa fever incidence, symptoms and coinfection with malaria in West Africa: the Enable Lassa Research Programme ('ENABLE 1.5') - study protocol.
Henshaw Mandi, Danny Asogun, Olufemi Ayodeji, Benedict N Azuogu, Anton Camacho, Paul Oloo

BMJ Public Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4-5 June 2024.
Radhika Gharpure, Carolin Vegvari, Alemseged Abdissa, Yewande Alimi, Assaf Anyamba, Paul Oloo

Vaccine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens.
Solomon Abebe Yimer, Birgitte Boonstra Booij, Gwen Tobert, Andrew Hebbeler, Paul Oloo

BMJ Glob Health· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccine development, production and regulatory oversight in African countries.
Geofrey Makenga, Robert Booy, Paul Ndaya Oloo, Joachim Auerbach

Bull World Health Organ· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial.
Martina Oneko, Laura C Steinhardt, Reuben Yego, Ryan E Wiegand, Phillip A Swanson, Paul Ndaya Oloo

Nat Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis